Similarly, PMN-MDSCs and TANs can be distinguished based on the recently discovered novel marker, lectin-type oxidized LDL receptor-1 (LOX-1), highly expressed in PMN-MDSCs isolated from peripheral blood of cancer patients (Condamine et al., 2016). Here, OLR1 is linked to cancer.